Updating The Most Recent Johnson's Baby Powder Cancer Trials
Staying abreast of the most recent developments for Johnson's Baby Powder cancer lawsuits
Thursday, March 21, 2024 - More trials are scheduled for 2024 after the most recent case fell victim to a hung jury. The case of Bob Sugarman vs. Johnson & Johnson was declared a mistrial and the plaintiff vowed to retry the case. This trial centered around allegations that Johnson & Johnson's talc-based baby powder led Bob Sugarman's wife to develop talcum powder ovarian cancer, resulting in her death. Despite extensive arguments, the Florida state court jury could not reach a unanimous verdict, leading to a mistrial. Johnson & Johnson maintained the safety of their product, asserting it does not contain asbestos or cause cancer, while the plaintiff's legal team expressed disappointment but anticipated a retrial. Johnson & Johnson's attorneys successfully argued that Sugarman's wife, an anesthetist working in a hospital, could have developed her case of mesothelioma from work and not necessarily from using Johnson's Baby Powder.
Before that, in November 2023, Johnson & Johnson settled two talcum powder lawsuits before they went to court. These cases were significant as they were the first trials since Johnson & Johnson's subsidiary, LTL Management, attempted to address its talc liabilities through bankruptcy. The details of the settlements, including the amounts, were not disclosed, marking a quiet resolution to what could have been publicly scrutinized trials. In October 2023, there was the reversal of a $224 million verdict against Johnson & Johnson giving the company new life in talcum powder cancer settlement negotiations. Also in a major legal turnaround, a New Jersey Appellate Division panel reversed a $224 million verdict against Johnson & Johnson awarded to four plaintiffs. The court criticized the trial court for not properly vetting the plaintiffs' expert testimony for reliability. This decision underscored the necessity for strict scrutiny of expert evidence in talcum powder litigation and set a precedent that may influence the approach in future cases. There are currently lawsuits against four of the plaintiff's expert witnesses for failing to disclose that their test patients may have had occupational or environmental exposure to asbestos.
The one loss incurred by Johnson & Johnson post-bankruptcy occurred in a California jury trial involving plaintiff Emory Hernandez Valadez. The trial in California was a pivotal moment in the ongoing litigation concerning J&J's talcum powder products. In this case, the jury awarded Anthony Hernandez Valadez, a man who claimed that J&J's baby powder played a significant role in causing his mesothelioma, $18.8 million. Mesothelioma is a rare form of cancer usually linked to asbestos exposure, and Valadez argued that he was exposed to asbestos through the regular use of J&J's talcum powder, starting from when he was a baby and continuing into his childhood. Valadez's lawsuit against J&J was part of a larger series of lawsuits alleging that the company's talcum powder products were contaminated with asbestos, a known carcinogen. During the trial, emotional testimonies were given, including from Valadez's mother, who expressed regret over using the talcum powder on her son not knowing about its alleged contamination. Finally, Marlin Eagles' talcum powder mesothelioma trial in Oakland, California marked the first talcum powder lawsuit against Johnson & Johnson following the failed bankruptcies of its subsidiary, LTL Management. Marlin Eagles, diagnosed with mesothelioma in 2022, attributed his condition to Johnson & Johnson's talcum powder. Johnson & Johnson, however, argued that Eagles' mesothelioma could be attributed to other sources of asbestos exposure, including his work at shipyards and Peterbilt. This case reflects the ongoing legal and scientific debates surrounding the safety of talcum powder and the responsibility of manufacturers.
OnderLaw, LLC -